Skip to main content
Erschienen in: Inflammation 3/2016

09.02.2016 | REVIEW

An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis

verfasst von: Zahra Ahmadi, Gholamhossein Hassanshahi, Hossein Khorramdelazad, Nahid Zainodini, Leila Koochakzadeh

Erschienen in: Inflammation | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Investigations revealed substantial parts accomplished by chemokines specifically eotaxins and their specific receptors. They are functionally involved in the modulation of the pathologic state of tissue inflammation which is as a result of allergic reactions. Chemokines as small proteins with approximately 8–10 kDa molecular weight are considered and fit in the bigger family of cytokines, containing basic heparin-binding polypeptide mediators. Chemokines actively interfere in the processes of selective, oriented leukocyte (including eosinophil) recruitment. As eminent from their name, more specifically, eotaxins are specialized for eosinophils’ oriented locomotion toward allergic inflamed regions. To date, three members are defined for eotaxin subfamily as follows: eotaxin-1 (CCL11), eotaxin-2 (CCL24), and eotaxin-3 (CCL26), all of them bind to and activate CCR3 but have a low level of homology and appear to exhibit different physiological potentials. Allergy is described as a clinical state in which a pathologic hypersensitivity reaction is always initiated throughout an immunologic mechanism; similar to other immunologic reactions, an allergic reaction could also either be antibody or cell mediated. This type of allergic reactions occurs in all age groups and damages several different organs, having a significant impact on the emotional and social health of patients and their families and relatives. Concerning introductory comments introduced above, the authors of the present review attempted to collect and provide the latest evidences and information regarding the correlation between expression of eotaxin family members and allergy, in a wider extent, in two important allergic disorders: atopic asthma (AA) and atopic dermatitis (AD). Overall, concerning the most recent articles published within the database in the life sciences literature regarding the fundamental role(s) played by eotaxins in the pathogenesis of AA and AD, the authors of the current article propose that eotaxins (CCL11, CCL24, and CCL26) play key role(s) during symptomatic inflammatory responses raised in response to allergic crisis of these two clinical states.
Literatur
2.
Zurück zum Zitat Patterson, R., P.A. Greenberger, J.M. Halwig, J.L. Liotta, and M. Roberts. 1986. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Archives of Internal Medicine 146: 916–918.PubMedCrossRef Patterson, R., P.A. Greenberger, J.M. Halwig, J.L. Liotta, and M. Roberts. 1986. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Archives of Internal Medicine 146: 916–918.PubMedCrossRef
3.
Zurück zum Zitat Husby, S. 1988. Dietary antigens: uptake and humoral immunity in man. Acta Pathologica, Microbiologica et Immunologica Scandinavica, Supplementum 1: 1–40. Husby, S. 1988. Dietary antigens: uptake and humoral immunity in man. Acta Pathologica, Microbiologica et Immunologica Scandinavica, Supplementum 1: 1–40.
4.
Zurück zum Zitat Kondo, N., H. Agata, O. Fukutomi, F. Motoyoshi, and T. Orii. 1990. Lymphocyte responses to food antigens in patients with atopic dermatitis who are sensitive to foods. Journal of Allergy and Clinical Immunology 86: 253–260.PubMedCrossRef Kondo, N., H. Agata, O. Fukutomi, F. Motoyoshi, and T. Orii. 1990. Lymphocyte responses to food antigens in patients with atopic dermatitis who are sensitive to foods. Journal of Allergy and Clinical Immunology 86: 253–260.PubMedCrossRef
5.
Zurück zum Zitat Halstensen, T.S., and P. Brandtzaeg. 1993. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. European Journal of Immunology 23: 505–510.PubMedCrossRef Halstensen, T.S., and P. Brandtzaeg. 1993. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. European Journal of Immunology 23: 505–510.PubMedCrossRef
6.
Zurück zum Zitat Gerber, B.O., M.P. Zanni, M. Uguccioni, M. Loetscher, C.R. Mackay, W.J. Pichler, et al. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Current Biology 7: 836–843.PubMedCrossRef Gerber, B.O., M.P. Zanni, M. Uguccioni, M. Loetscher, C.R. Mackay, W.J. Pichler, et al. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Current Biology 7: 836–843.PubMedCrossRef
7.
Zurück zum Zitat Gonzalo, J.A., C.M. Lloyd, L. Kremer, E. Finger, A.C. Martinez, M.H. Siegelman, et al. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. The Journal of Clinical Investigation 98: 2332–2345.PubMedPubMedCentralCrossRef Gonzalo, J.A., C.M. Lloyd, L. Kremer, E. Finger, A.C. Martinez, M.H. Siegelman, et al. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. The Journal of Clinical Investigation 98: 2332–2345.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Schroder, J.M., N. Noso, M. Sticherling, and E. Christophers. 1996. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. Journal of Leukocyte Biology 59: 1–5.PubMed Schroder, J.M., N. Noso, M. Sticherling, and E. Christophers. 1996. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. Journal of Leukocyte Biology 59: 1–5.PubMed
9.
Zurück zum Zitat Radman, M., G. Hassanshahi, R. Vazirinejad, M.K. Arababadi, M.N. Karimabad, H. Khorramdelazad, et al. 2013. Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations. Inflammation 36: 561–566.PubMedCrossRef Radman, M., G. Hassanshahi, R. Vazirinejad, M.K. Arababadi, M.N. Karimabad, H. Khorramdelazad, et al. 2013. Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations. Inflammation 36: 561–566.PubMedCrossRef
10.
Zurück zum Zitat Morita, A., K. Shimosako, S. Kikuoka, Y. Taniguchi, M. Kitaura, K. Sasakura, et al. 1999. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. Journal of Immunological Methods 226: 159–167.PubMedCrossRef Morita, A., K. Shimosako, S. Kikuoka, Y. Taniguchi, M. Kitaura, K. Sasakura, et al. 1999. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. Journal of Immunological Methods 226: 159–167.PubMedCrossRef
11.
Zurück zum Zitat Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. The Journal of Clinical Investigation 97: 604–612.PubMedPubMedCentralCrossRef Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. The Journal of Clinical Investigation 97: 604–612.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Uguccioni, M., C.R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G.J. LaRosa, et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. The Journal of Clinical Investigation 100: 1137–1143.PubMedPubMedCentralCrossRef Uguccioni, M., C.R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G.J. LaRosa, et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. The Journal of Clinical Investigation 100: 1137–1143.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Ying, S., L. Taborda-Barata, Q. Meng, M. Humbert, and A.B. Kay. 1995. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. The Journal of Experimental Medicine 181: 2153–2159.PubMedCrossRef Ying, S., L. Taborda-Barata, Q. Meng, M. Humbert, and A.B. Kay. 1995. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. The Journal of Experimental Medicine 181: 2153–2159.PubMedCrossRef
14.
Zurück zum Zitat Rubbert, A., C. Combadiere, M. Ostrowski, J. Arthos, M. Dybul, E. Machado, et al. 1998. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. The Journal of Immunology 160: 3933–3941.PubMed Rubbert, A., C. Combadiere, M. Ostrowski, J. Arthos, M. Dybul, E. Machado, et al. 1998. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. The Journal of Immunology 160: 3933–3941.PubMed
15.
Zurück zum Zitat Bradley, B.L., M. Azzawi, M. Jacobson, B. Assoufi, J.V. Collins, A.M. Irani, et al. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. Journal of Allergy and Clinical Immunology 88: 661–674.PubMedCrossRef Bradley, B.L., M. Azzawi, M. Jacobson, B. Assoufi, J.V. Collins, A.M. Irani, et al. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. Journal of Allergy and Clinical Immunology 88: 661–674.PubMedCrossRef
16.
Zurück zum Zitat Griffiths-Johnson, D.A., P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochemical and Biophysical Research Communications 197: 1167–1172.PubMedCrossRef Griffiths-Johnson, D.A., P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochemical and Biophysical Research Communications 197: 1167–1172.PubMedCrossRef
17.
Zurück zum Zitat Rothenberg, M.E., and S.P. Hogan. 2006. The eosinophil. Annual Review of Immunology 24: 147–174.PubMedCrossRef Rothenberg, M.E., and S.P. Hogan. 2006. The eosinophil. Annual Review of Immunology 24: 147–174.PubMedCrossRef
18.
Zurück zum Zitat Garcia-Zepeda, E.A., M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Natue Medicine 2: 449–456.CrossRef Garcia-Zepeda, E.A., M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Natue Medicine 2: 449–456.CrossRef
19.
Zurück zum Zitat Rot, A., M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. Journal of Experimental Medicine 176: 1489–1495.PubMedCrossRef Rot, A., M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. Journal of Experimental Medicine 176: 1489–1495.PubMedCrossRef
20.
Zurück zum Zitat Weber, M., M. Uguccioni, B. Ochensberger, M. Baggiolini, I. Clark-Lewis, and C.A. Dahinden. 1995. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. The Journal of Immunology 154: 4166–4172.PubMed Weber, M., M. Uguccioni, B. Ochensberger, M. Baggiolini, I. Clark-Lewis, and C.A. Dahinden. 1995. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. The Journal of Immunology 154: 4166–4172.PubMed
21.
Zurück zum Zitat Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, et al. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. Journal of Experimental Medicine 179: 751–756.PubMedCrossRef Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, et al. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. Journal of Experimental Medicine 179: 751–756.PubMedCrossRef
22.
Zurück zum Zitat Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S.H. Lima, et al. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. Journal of Experimental Medicine 183: 2379–2384.PubMedCrossRef Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S.H. Lima, et al. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. Journal of Experimental Medicine 183: 2379–2384.PubMedCrossRef
23.
Zurück zum Zitat Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Advanced of Immunology 55: 97–179.CrossRef Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Advanced of Immunology 55: 97–179.CrossRef
24.
Zurück zum Zitat Honda, K., and J. Chihara. 1999. Eosinophil activation by eotaxin—eotaxin primes the production of reactive oxygen species from eosinophils. Allergy 54: 1262–1269.PubMedCrossRef Honda, K., and J. Chihara. 1999. Eosinophil activation by eotaxin—eotaxin primes the production of reactive oxygen species from eosinophils. Allergy 54: 1262–1269.PubMedCrossRef
25.
Zurück zum Zitat El-Shazly, A., and T. Ishikawa. 1999. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release. Mediators of Inflammation 8: 177–179.PubMedPubMedCentralCrossRef El-Shazly, A., and T. Ishikawa. 1999. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release. Mediators of Inflammation 8: 177–179.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G.W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. The Journal of Clinical Investigation 101: 2129–2139.PubMedPubMedCentralCrossRef Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G.W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. The Journal of Clinical Investigation 101: 2129–2139.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Izumi, S., K. Hirai, M. Miyamasu, Y. Takahashi, Y. Misaki, T. Takaishi, et al. 1997. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. European Journal of Immunology 27: 816–824.PubMedCrossRef Izumi, S., K. Hirai, M. Miyamasu, Y. Takahashi, Y. Misaki, T. Takaishi, et al. 1997. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. European Journal of Immunology 27: 816–824.PubMedCrossRef
28.
Zurück zum Zitat Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, et al. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. The Journal of Clinical Investigation 99: 178–184.PubMedPubMedCentralCrossRef Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, et al. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. The Journal of Clinical Investigation 99: 178–184.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Jose, P., D. Griffiths-Johnson, P. Collins, D. Walsh, R. Moqbel, N. Totty, et al. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. The Journal of Experimental Medicine 179: 881–887.PubMedCrossRef Jose, P., D. Griffiths-Johnson, P. Collins, D. Walsh, R. Moqbel, N. Totty, et al. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. The Journal of Experimental Medicine 179: 881–887.PubMedCrossRef
30.
Zurück zum Zitat Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proceedings of the National Academy of Sciences 92: 8960–8964.CrossRef Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proceedings of the National Academy of Sciences 92: 8960–8964.CrossRef
31.
Zurück zum Zitat Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, et al. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. Journal of Biological Chemistry 271: 7725–7730.PubMedCrossRef Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, et al. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. Journal of Biological Chemistry 271: 7725–7730.PubMedCrossRef
32.
Zurück zum Zitat Garcia-Zepeda, E.A., M.E. Rothenberg, S. Weremowicz, M.N. Sarafi, C.C. Morton, and A.D. Luster. 1997. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics 41: 471–476.PubMedCrossRef Garcia-Zepeda, E.A., M.E. Rothenberg, S. Weremowicz, M.N. Sarafi, C.C. Morton, and A.D. Luster. 1997. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics 41: 471–476.PubMedCrossRef
33.
Zurück zum Zitat Bartels, J., C. Schlüter, E. Richter, N. Noso, R. Kulke, E. Christophers, et al. 1996. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochemical and Biophysical Research Communications 225: 1045–1051.PubMedCrossRef Bartels, J., C. Schlüter, E. Richter, N. Noso, R. Kulke, E. Christophers, et al. 1996. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochemical and Biophysical Research Communications 225: 1045–1051.PubMedCrossRef
34.
Zurück zum Zitat Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. The Journal of Experimental Medicine 183: 2437–2448.PubMedCrossRef Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. The Journal of Experimental Medicine 183: 2437–2448.PubMedCrossRef
35.
Zurück zum Zitat Ying, S., D.S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D.J. Ringler, et al. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells. European Journal of Immunology 27: 3507–3516.PubMedCrossRef Ying, S., D.S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D.J. Ringler, et al. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells. European Journal of Immunology 27: 3507–3516.PubMedCrossRef
36.
Zurück zum Zitat Ying, S., D.S. Robinson, Q. Meng, L.T. Barata, A.R. McEuen, M.G. Buckley, et al. 1999. CC chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other CC chemokines (monocyte chemoattractant protein-3 and RANTES). The Journal of Immunology 163: 3976–3984.PubMed Ying, S., D.S. Robinson, Q. Meng, L.T. Barata, A.R. McEuen, M.G. Buckley, et al. 1999. CC chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other CC chemokines (monocyte chemoattractant protein-3 and RANTES). The Journal of Immunology 163: 3976–3984.PubMed
37.
Zurück zum Zitat Miyamasu, M., M. Yamaguchi, T. Nakajima, Y. Misaki, Y. Morita, K. Matsushima, et al. 1999. Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro. International Immunology 11: 1001–1004.PubMedCrossRef Miyamasu, M., M. Yamaguchi, T. Nakajima, Y. Misaki, Y. Morita, K. Matsushima, et al. 1999. Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro. International Immunology 11: 1001–1004.PubMedCrossRef
38.
Zurück zum Zitat Hein, H., C. Schlüter, R. Kulke, E. Christophers, J.-M. Schröder, and J. Bartels. 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochemical and Biophysical Research Communications 237: 537–542.PubMedCrossRef Hein, H., C. Schlüter, R. Kulke, E. Christophers, J.-M. Schröder, and J. Bartels. 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochemical and Biophysical Research Communications 237: 537–542.PubMedCrossRef
39.
Zurück zum Zitat Mochizuki, M., J. Bartels, A.I. Mallet, E. Christophers, and J.-M. Schröder. 1998. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. The Journal of Immunology 160: 60–68.PubMed Mochizuki, M., J. Bartels, A.I. Mallet, E. Christophers, and J.-M. Schröder. 1998. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. The Journal of Immunology 160: 60–68.PubMed
40.
Zurück zum Zitat Li, L., Y. Xia, A. Nguyen, Y.H. Lai, L. Feng, T.R. Mosmann, et al. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. The Journal of Immunology 162: 2477–2487.PubMed Li, L., Y. Xia, A. Nguyen, Y.H. Lai, L. Feng, T.R. Mosmann, et al. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. The Journal of Immunology 162: 2477–2487.PubMed
41.
Zurück zum Zitat Matsukura, S., C. Stellato, J.R. Plitt, C. Bickel, K. Miura, S.N. Georas, et al. 1999. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells. The Journal of Immunology 163: 6876–6883.PubMed Matsukura, S., C. Stellato, J.R. Plitt, C. Bickel, K. Miura, S.N. Georas, et al. 1999. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells. The Journal of Immunology 163: 6876–6883.PubMed
42.
Zurück zum Zitat Amerio, P., A. Frezzolini, C. Feliciani, R. Verdolini, P. Teofoli, O. Pit, et al. 2003. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Current Drug Targets-Inflammation & Allergy 2: 81–94.CrossRef Amerio, P., A. Frezzolini, C. Feliciani, R. Verdolini, P. Teofoli, O. Pit, et al. 2003. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Current Drug Targets-Inflammation & Allergy 2: 81–94.CrossRef
43.
Zurück zum Zitat Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005–2007.PubMedCrossRef Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005–2007.PubMedCrossRef
44.
Zurück zum Zitat Romagnani, P., A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, et al. 1999. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. The American Journal of Pathology 155: 1195–1204.PubMedPubMedCentralCrossRef Romagnani, P., A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, et al. 1999. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. The American Journal of Pathology 155: 1195–1204.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Palframan, R.T., P.D. Collins, T.J. Williams, and S.M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91: 2240–2248.PubMed Palframan, R.T., P.D. Collins, T.J. Williams, and S.M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91: 2240–2248.PubMed
46.
Zurück zum Zitat Taha, R.A., E.M. Minshall, D.Y. Leung, M. Boguniewicz, A. Luster, S. Muro, et al. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Journal of Allergy and Clinical Immunology 105: 1002–1007.PubMedCrossRef Taha, R.A., E.M. Minshall, D.Y. Leung, M. Boguniewicz, A. Luster, S. Muro, et al. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Journal of Allergy and Clinical Immunology 105: 1002–1007.PubMedCrossRef
47.
Zurück zum Zitat Kitayama, J., R.C. Fuhlbrigge, K.D. Puri, and T.A. Springer. 1997. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. The Journal of Immunology 159: 3929–3939.PubMed Kitayama, J., R.C. Fuhlbrigge, K.D. Puri, and T.A. Springer. 1997. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. The Journal of Immunology 159: 3929–3939.PubMed
48.
Zurück zum Zitat Hohki, G., N. Terada, N. Hamano, M. Kitaura, T. Nakajima, O. Yoshie, et al. 1997. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochemical and Biophysical Research Communications 241: 136–141.PubMedCrossRef Hohki, G., N. Terada, N. Hamano, M. Kitaura, T. Nakajima, O. Yoshie, et al. 1997. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochemical and Biophysical Research Communications 241: 136–141.PubMedCrossRef
49.
Zurück zum Zitat Sabroe, I., D.M. Conroy, N.P. Gerard, Y. Li, P.D. Collins, T.W. Post, et al. 1998. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, CC chemokine receptor-3: blockade using a monoclonal antibody in vivo. The Journal of Immunology 161: 6139–6147.PubMed Sabroe, I., D.M. Conroy, N.P. Gerard, Y. Li, P.D. Collins, T.W. Post, et al. 1998. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, CC chemokine receptor-3: blockade using a monoclonal antibody in vivo. The Journal of Immunology 161: 6139–6147.PubMed
50.
Zurück zum Zitat Jia, G.-Q., J.-A. Gonzalo, A. Hidalgo, D. Wagner, M. Cybulsky, and J.C. Gutierrez-Ramos. 1999. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. International Immunology 11: 1–10.PubMedCrossRef Jia, G.-Q., J.-A. Gonzalo, A. Hidalgo, D. Wagner, M. Cybulsky, and J.C. Gutierrez-Ramos. 1999. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. International Immunology 11: 1–10.PubMedCrossRef
51.
Zurück zum Zitat Gutierrez-Ramos, J.C., C. Lloyd, and J.A. Gonzalo. 1999. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunology Today 20: 500–504.PubMedCrossRef Gutierrez-Ramos, J.C., C. Lloyd, and J.A. Gonzalo. 1999. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunology Today 20: 500–504.PubMedCrossRef
52.
Zurück zum Zitat Petering, H., C. Kluthe, Y. Dulkys, P. Kiehl, P.D. Ponath, A. Kapp, et al. 2001. Characterization of the CC chemokine receptor 3 on human keratinocytes. Journal of Investigative Dermatology 116: 549–555.PubMedCrossRef Petering, H., C. Kluthe, Y. Dulkys, P. Kiehl, P.D. Ponath, A. Kapp, et al. 2001. Characterization of the CC chemokine receptor 3 on human keratinocytes. Journal of Investigative Dermatology 116: 549–555.PubMedCrossRef
53.
Zurück zum Zitat Salcedo, R., H.A. Young, M.L. Ponce, J.M. Ward, H.K. Kleinman, W.J. Murphy, et al. 2001. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. The Journal of Immunology 166: 7571–7578.PubMedCrossRef Salcedo, R., H.A. Young, M.L. Ponce, J.M. Ward, H.K. Kleinman, W.J. Murphy, et al. 2001. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. The Journal of Immunology 166: 7571–7578.PubMedCrossRef
54.
Zurück zum Zitat Nomiyama, H., L. Osborne, T. Imai, J. Kusuda, R. Miura, L.-C. Tsui, et al. 1998. Assignment of the human CC chemokine MPIF-2/eotaxin-2 (SCYA24) to chromosome 7q11.23. Genomics 49: 339–340.PubMedCrossRef Nomiyama, H., L. Osborne, T. Imai, J. Kusuda, R. Miura, L.-C. Tsui, et al. 1998. Assignment of the human CC chemokine MPIF-2/eotaxin-2 (SCYA24) to chromosome 7q11.23. Genomics 49: 339–340.PubMedCrossRef
55.
Zurück zum Zitat Jahnsen, F.L., R. Haye, E. Gran, P. Brandtzaeg, and F.-E. Johansen. 1999. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. The Journal of Immunology 163: 1545–1551.PubMed Jahnsen, F.L., R. Haye, E. Gran, P. Brandtzaeg, and F.-E. Johansen. 1999. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. The Journal of Immunology 163: 1545–1551.PubMed
56.
Zurück zum Zitat Dulkys, Y., G. Schramm, D. Kimmig, S. Knöß, A. Weyergraf, A. Kapp, et al. 2001. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. Journal of Investigative Dermatology 116: 498–505.PubMedCrossRef Dulkys, Y., G. Schramm, D. Kimmig, S. Knöß, A. Weyergraf, A. Kapp, et al. 2001. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. Journal of Investigative Dermatology 116: 498–505.PubMedCrossRef
57.
Zurück zum Zitat Shahabuddin, S., P. Ponath, and R.P. Schleimer. 2000. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and CC chemokines. The Journal of Immunology 164: 3847–3854.PubMedCrossRef Shahabuddin, S., P. Ponath, and R.P. Schleimer. 2000. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and CC chemokines. The Journal of Immunology 164: 3847–3854.PubMedCrossRef
58.
Zurück zum Zitat Patel, V.P., B.L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo, et al. 1997. Molecular and functional characterization of two novel human CC chemokines as inhibitors of two distinct classes of myeloid progenitors. The Journal of Experimental Medicine 185: 1163–1172.PubMedPubMedCentralCrossRef Patel, V.P., B.L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo, et al. 1997. Molecular and functional characterization of two novel human CC chemokines as inhibitors of two distinct classes of myeloid progenitors. The Journal of Experimental Medicine 185: 1163–1172.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Heinemann, A., A. Hartnell, V.E. Stubbs, K. Murakami, D. Soler, G. LaRosa, et al. 2000. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. The Journal of Immunology 165: 7224–7233.PubMedCrossRef Heinemann, A., A. Hartnell, V.E. Stubbs, K. Murakami, D. Soler, G. LaRosa, et al. 2000. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. The Journal of Immunology 165: 7224–7233.PubMedCrossRef
60.
Zurück zum Zitat Maune, S., and J. Meyer. 2002. The role of CC chemokines in chronic sinusitis. Oto-Rhino-Laryngologia Nova 12: 63–70.CrossRef Maune, S., and J. Meyer. 2002. The role of CC chemokines in chronic sinusitis. Oto-Rhino-Laryngologia Nova 12: 63–70.CrossRef
61.
Zurück zum Zitat Hoeck, J., and M. Woisetschläger. 2001. Activation of eotaxin-3/CCL26 gene expression in human dermal fibroblasts is mediated by STAT6. The Journal of Immunology 167: 3216–3222.PubMedCrossRef Hoeck, J., and M. Woisetschläger. 2001. Activation of eotaxin-3/CCL26 gene expression in human dermal fibroblasts is mediated by STAT6. The Journal of Immunology 167: 3216–3222.PubMedCrossRef
62.
Zurück zum Zitat Shinkai, A., H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, et al. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. The Journal of Immunology 163: 1602–1610.PubMed Shinkai, A., H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, et al. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. The Journal of Immunology 163: 1602–1610.PubMed
64.
Zurück zum Zitat Kitaura, M., N. Suzuki, T. Imai, S. Takagi, R. Suzuki, T. Nakajima, et al. 1999. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 274: 27975–27980.PubMedCrossRef Kitaura, M., N. Suzuki, T. Imai, S. Takagi, R. Suzuki, T. Nakajima, et al. 1999. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 274: 27975–27980.PubMedCrossRef
65.
Zurück zum Zitat Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annual Review of Immunology 17: 255–281.PubMedCrossRef Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annual Review of Immunology 17: 255–281.PubMedCrossRef
66.
Zurück zum Zitat Maddox, L., and D.A. Schwartz. 2002. The pathophysiology of asthma. Annual Review of Medicine 53: 477–498.PubMedCrossRef Maddox, L., and D.A. Schwartz. 2002. The pathophysiology of asthma. Annual Review of Medicine 53: 477–498.PubMedCrossRef
67.
Zurück zum Zitat Hatae, T., M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe. 2001. Prostacyclin-dependent apoptosis mediated by PPAR delta. The Journal of Biological Chemistry 276: 46260–46267.PubMedCrossRef Hatae, T., M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe. 2001. Prostacyclin-dependent apoptosis mediated by PPAR delta. The Journal of Biological Chemistry 276: 46260–46267.PubMedCrossRef
68.
Zurück zum Zitat Daynes, R.A., and D.C. Jones. 2002. Emerging roles of PPARs in inflammation and immunity. Nature Reviews Immunology 2: 748–759.PubMedCrossRef Daynes, R.A., and D.C. Jones. 2002. Emerging roles of PPARs in inflammation and immunity. Nature Reviews Immunology 2: 748–759.PubMedCrossRef
69.
Zurück zum Zitat Clark, R.B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S.J. Padula. 2000. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. The Journal of Immunology 164: 1364–1371.PubMedCrossRef Clark, R.B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S.J. Padula. 2000. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. The Journal of Immunology 164: 1364–1371.PubMedCrossRef
70.
Zurück zum Zitat Chinetti, G., S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, et al. 1998. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. The Journal of Biological Chemistry 273: 25573–25580.PubMedCrossRef Chinetti, G., S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, et al. 1998. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. The Journal of Biological Chemistry 273: 25573–25580.PubMedCrossRef
71.
Zurück zum Zitat Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79–82.PubMedCrossRef Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79–82.PubMedCrossRef
72.
Zurück zum Zitat Devchand, P.R., H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39–43.PubMedCrossRef Devchand, P.R., H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39–43.PubMedCrossRef
73.
Zurück zum Zitat Fujisawa, T., Y. Kato, H. Nagase, J. Atsuta, A. Terada, K. Iguchi, et al. 2000. Chemokines induce eosinophil degranulation through CCR-3. Journal of Allergy and Clinical Immunology 106: 507–513.PubMedCrossRef Fujisawa, T., Y. Kato, H. Nagase, J. Atsuta, A. Terada, K. Iguchi, et al. 2000. Chemokines induce eosinophil degranulation through CCR-3. Journal of Allergy and Clinical Immunology 106: 507–513.PubMedCrossRef
74.
Zurück zum Zitat Han, S.J., J.H. Kim, Y.J. Noh, H.S. Chang, C.S. Kim, K.S. Kim, et al. 1999. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils. American Journal of Respiratory Cell and Molecular Biology 21: 303–310.PubMedCrossRef Han, S.J., J.H. Kim, Y.J. Noh, H.S. Chang, C.S. Kim, K.S. Kim, et al. 1999. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils. American Journal of Respiratory Cell and Molecular Biology 21: 303–310.PubMedCrossRef
75.
Zurück zum Zitat Zhou, X., H. Hu, S. Balzar, J.B. Trudeau, and S.E. Wenzel. 2012. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-beta1 and IL-13 in human airway fibroblasts. The Journal of Immunology 188: 6046–6054.PubMedPubMedCentralCrossRef Zhou, X., H. Hu, S. Balzar, J.B. Trudeau, and S.E. Wenzel. 2012. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-beta1 and IL-13 in human airway fibroblasts. The Journal of Immunology 188: 6046–6054.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Wenzel, S.E., J.B. Trudeau, S. Barnes, X. Zhou, M. Cundall, J.Y. Westcott, et al. 2002. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. The Journal of Immunology 169: 4613–4619.PubMedCrossRef Wenzel, S.E., J.B. Trudeau, S. Barnes, X. Zhou, M. Cundall, J.Y. Westcott, et al. 2002. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. The Journal of Immunology 169: 4613–4619.PubMedCrossRef
77.
Zurück zum Zitat Hoeck, J., and M. Woisetschlager. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. The Journal of Immunology 166: 4507–4515.PubMedCrossRef Hoeck, J., and M. Woisetschlager. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. The Journal of Immunology 166: 4507–4515.PubMedCrossRef
78.
Zurück zum Zitat Matsukura, S., M. Odaka, M. Kurokawa, H. Kuga, T. Homma, H. Takeuchi, et al. 2010. Transforming growth factor-beta stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-kappabeta in airway smooth muscle cells. Clinical & Experimental Allergy 40: 763–771. Matsukura, S., M. Odaka, M. Kurokawa, H. Kuga, T. Homma, H. Takeuchi, et al. 2010. Transforming growth factor-beta stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-kappabeta in airway smooth muscle cells. Clinical & Experimental Allergy 40: 763–771.
79.
Zurück zum Zitat Kumagai, N., K. Fukuda, Y. Ishimura, and T. Nishida. 2000. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13. Investigative Ophthalmology & Visual Science 41: 1448–1453. Kumagai, N., K. Fukuda, Y. Ishimura, and T. Nishida. 2000. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13. Investigative Ophthalmology & Visual Science 41: 1448–1453.
80.
Zurück zum Zitat Liu, Y., C. Meyer, A. Muller, F. Herweck, Q. Li, R. Mullenbach, et al. 2011. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling. The Journal of Immunology 187: 2814–2823.PubMedCrossRef Liu, Y., C. Meyer, A. Muller, F. Herweck, Q. Li, R. Mullenbach, et al. 2011. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling. The Journal of Immunology 187: 2814–2823.PubMedCrossRef
81.
Zurück zum Zitat Zheng, T., Z. Zhu, W. Liu, C.G. Lee, Q. Chen, R.J. Homer, et al. 2003. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. Journal of Allergy and Clinical Immunology 111: 720–728.PubMedCrossRef Zheng, T., Z. Zhu, W. Liu, C.G. Lee, Q. Chen, R.J. Homer, et al. 2003. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. Journal of Allergy and Clinical Immunology 111: 720–728.PubMedCrossRef
82.
Zurück zum Zitat Hirst, S.J., M.P. Hallsworth, Q. Peng, and T.H. Lee. 2002. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. American Journal of Respiratory Cell and Molecular Biology 165: 1161–1171. Hirst, S.J., M.P. Hallsworth, Q. Peng, and T.H. Lee. 2002. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. American Journal of Respiratory Cell and Molecular Biology 165: 1161–1171.
83.
Zurück zum Zitat Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunology Today 15: 127–133.PubMedCrossRef Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunology Today 15: 127–133.PubMedCrossRef
84.
Zurück zum Zitat Aceves, S.S., R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide. 2007. Esophageal remodeling in pediatric eosinophilic esophagitis. Journal of Allergy and Clinical Immunology 119: 206–212.PubMedCrossRef Aceves, S.S., R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide. 2007. Esophageal remodeling in pediatric eosinophilic esophagitis. Journal of Allergy and Clinical Immunology 119: 206–212.PubMedCrossRef
85.
Zurück zum Zitat Kephart, G.M., J.A. Alexander, A.S. Arora, Y. Romero, T.C. Smyrk, N.J. Talley, et al. 2010. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. The American Journal of Gastroenterology 105: 298–307.PubMedPubMedCentralCrossRef Kephart, G.M., J.A. Alexander, A.S. Arora, Y. Romero, T.C. Smyrk, N.J. Talley, et al. 2010. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. The American Journal of Gastroenterology 105: 298–307.PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Cheng, E., R.F. Souza, and S.J. Spechler. 2012. Tissue remodeling in eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 303: G1175–G1187.PubMedPubMedCentralCrossRef Cheng, E., R.F. Souza, and S.J. Spechler. 2012. Tissue remodeling in eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 303: G1175–G1187.PubMedPubMedCentralCrossRef
87.
Zurück zum Zitat Abonia, J.P., J.P. Franciosi, and M.E. Rothenberg. 2010. TGFβ1: mediator of a feedback loop in eosinophilic esophagitis… or should we really say mastocytic esophagitis? The Journal of Allergy and Clinical Immunology 126: 1205.PubMedPubMedCentralCrossRef Abonia, J.P., J.P. Franciosi, and M.E. Rothenberg. 2010. TGFβ1: mediator of a feedback loop in eosinophilic esophagitis… or should we really say mastocytic esophagitis? The Journal of Allergy and Clinical Immunology 126: 1205.PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Hogan, S.P., and M.E. Rothenberg. 2006. Eosinophil function in eosinophil-associated gastrointestinal disorders. Current Allergy and Asthma Reports 6: 65–71.PubMedCrossRef Hogan, S.P., and M.E. Rothenberg. 2006. Eosinophil function in eosinophil-associated gastrointestinal disorders. Current Allergy and Asthma Reports 6: 65–71.PubMedCrossRef
89.
Zurück zum Zitat Odemuyiwa, S.O., A. Ghahary, Y. Li, L. Puttagunta, J.E. Lee, S. Musat-Marcu, et al. 2004. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. The Journal of Immunology 173: 5909–5913.PubMedCrossRef Odemuyiwa, S.O., A. Ghahary, Y. Li, L. Puttagunta, J.E. Lee, S. Musat-Marcu, et al. 2004. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. The Journal of Immunology 173: 5909–5913.PubMedCrossRef
90.
Zurück zum Zitat Lucendo, A.J., T. Bellón, and B. Lucendo. 2009. The role of mast cells in eosinophilic esophagitis. Pediatric Allergy and Immunology 20: 512–518.PubMedCrossRef Lucendo, A.J., T. Bellón, and B. Lucendo. 2009. The role of mast cells in eosinophilic esophagitis. Pediatric Allergy and Immunology 20: 512–518.PubMedCrossRef
91.
Zurück zum Zitat Konikoff, M.R., R.J. Noel, C. Blanchard, C. Kirby, S.C. Jameson, B.K. Buckmeier, et al. 2006. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131: 1381–1391.PubMedCrossRef Konikoff, M.R., R.J. Noel, C. Blanchard, C. Kirby, S.C. Jameson, B.K. Buckmeier, et al. 2006. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131: 1381–1391.PubMedCrossRef
92.
Zurück zum Zitat Aceves, S., R. Newbury, D. Chen, J. Mueller, R. Dohil, H. Hoffman, et al. 2010. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 65: 109–116.PubMedPubMedCentralCrossRef Aceves, S., R. Newbury, D. Chen, J. Mueller, R. Dohil, H. Hoffman, et al. 2010. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 65: 109–116.PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Chai, O.H., E.-H. Han, H.-K. Lee, and C.H. Song. 2011. Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-α. Experimental & Molecular Medicine 43: 35–43.CrossRef Chai, O.H., E.-H. Han, H.-K. Lee, and C.H. Song. 2011. Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-α. Experimental & Molecular Medicine 43: 35–43.CrossRef
94.
Zurück zum Zitat Vicario, M., C. Blanchard, K.F. Stringer, M.H. Collins, M.K. Mingler, A. Ahrens, et al. 2010. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 59: 12–20.PubMedPubMedCentralCrossRef Vicario, M., C. Blanchard, K.F. Stringer, M.H. Collins, M.K. Mingler, A. Ahrens, et al. 2010. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 59: 12–20.PubMedPubMedCentralCrossRef
95.
Zurück zum Zitat Gonsalves, N., G.Y. Yang, B. Doerfler, S. Ritz, A.M. Ditto, and I. Hirano. 2012. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 142: 1451–1459. e1451.PubMedCrossRef Gonsalves, N., G.Y. Yang, B. Doerfler, S. Ritz, A.M. Ditto, and I. Hirano. 2012. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 142: 1451–1459. e1451.PubMedCrossRef
96.
Zurück zum Zitat Rajavelu, P., M. Rayapudi, M. Moffitt, A. Mishra, and A. Mishra. 2012. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 302: G645–G654.PubMedPubMedCentralCrossRef Rajavelu, P., M. Rayapudi, M. Moffitt, A. Mishra, and A. Mishra. 2012. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 302: G645–G654.PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat Blanchard, C., M.K. Mingler, M. Vicario, J.P. Abonia, Y.Y. Wu, T.X. Lu, et al. 2007. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. Journal of Allergy and Clinical Immunology 120: 1292–1300.PubMedCrossRef Blanchard, C., M.K. Mingler, M. Vicario, J.P. Abonia, Y.Y. Wu, T.X. Lu, et al. 2007. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. Journal of Allergy and Clinical Immunology 120: 1292–1300.PubMedCrossRef
98.
Zurück zum Zitat Yamazaki, K., J.A. Murray, A.S. Arora, J.A. Alexander, T.C. Smyrk, J.H. Butterfield, et al. 2006. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Digestive Diseases and Sciences 51: 1934–1941.PubMedCrossRef Yamazaki, K., J.A. Murray, A.S. Arora, J.A. Alexander, T.C. Smyrk, J.H. Butterfield, et al. 2006. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Digestive Diseases and Sciences 51: 1934–1941.PubMedCrossRef
99.
Zurück zum Zitat Otani, I.M., A.A. Anilkumar, R.O. Newbury, M. Bhagat, L.Y. Beppu, R. Dohil, et al. 2013. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology 131: 1576–1582. e1572.PubMedPubMedCentralCrossRef Otani, I.M., A.A. Anilkumar, R.O. Newbury, M. Bhagat, L.Y. Beppu, R. Dohil, et al. 2013. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology 131: 1576–1582. e1572.PubMedPubMedCentralCrossRef
100.
Zurück zum Zitat Umetsu, D.T., J.J. McIntire, O. Akbari, C. Macaubas, and R.H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nature Immunology 3: 715–720.PubMedCrossRef Umetsu, D.T., J.J. McIntire, O. Akbari, C. Macaubas, and R.H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nature Immunology 3: 715–720.PubMedCrossRef
101.
Zurück zum Zitat Holt, P.G., C. Macaubas, P.A. Stumbles, and P.D. Sly. 1999. The role of allergy in the development of asthma. Nature 402: B12–17.PubMedCrossRef Holt, P.G., C. Macaubas, P.A. Stumbles, and P.D. Sly. 1999. The role of allergy in the development of asthma. Nature 402: B12–17.PubMedCrossRef
102.
Zurück zum Zitat Jahnz-Rozyk, K., L.B. Brydak, T. Targowski, M. Machala, and T. Plusa. 2004. Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma. Mediators of Inflammation 13: 195–199.PubMedPubMedCentralCrossRef Jahnz-Rozyk, K., L.B. Brydak, T. Targowski, M. Machala, and T. Plusa. 2004. Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma. Mediators of Inflammation 13: 195–199.PubMedPubMedCentralCrossRef
103.
Zurück zum Zitat Bousquet, J., P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory Critical Care Medicine 161: 1720–1745.PubMedCrossRef Bousquet, J., P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory Critical Care Medicine 161: 1720–1745.PubMedCrossRef
104.
Zurück zum Zitat Kelly, M., J.M. Hwang, and P. Kubes. 2007. Modulating leukocyte recruitment in inflammation. Journal of Allergy and Clinical Immunology 120: 3–10.PubMedCrossRef Kelly, M., J.M. Hwang, and P. Kubes. 2007. Modulating leukocyte recruitment in inflammation. Journal of Allergy and Clinical Immunology 120: 3–10.PubMedCrossRef
105.
Zurück zum Zitat Komiya, A., H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, et al. 2003. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cellular Immunology 225: 91–100.PubMedCrossRef Komiya, A., H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, et al. 2003. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cellular Immunology 225: 91–100.PubMedCrossRef
106.
Zurück zum Zitat Collins, P.D., S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. The Journal of Experimental Medicine 182: 1169–1174.PubMedCrossRef Collins, P.D., S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. The Journal of Experimental Medicine 182: 1169–1174.PubMedCrossRef
107.
Zurück zum Zitat Humbles, A.A., B. Lu, D.S. Friend, S. Okinaga, J. Lora, A. Al-Garawi, et al. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proceeding of the National Academy of Sciences of the United States of America 99: 1479–1484.CrossRef Humbles, A.A., B. Lu, D.S. Friend, S. Okinaga, J. Lora, A. Al-Garawi, et al. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proceeding of the National Academy of Sciences of the United States of America 99: 1479–1484.CrossRef
108.
Zurück zum Zitat Berkman, N., S. Ohnona, F.K. Chung, and R. Breuer. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 24: 682–687.PubMedCrossRef Berkman, N., S. Ohnona, F.K. Chung, and R. Breuer. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 24: 682–687.PubMedCrossRef
109.
Zurück zum Zitat McElhaney, J.E., C.M. Upshaw, J.W. Hooton, K.E. Lechelt, and G.S. Meneilly. 1998. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 16: 1742–1747.PubMedCrossRef McElhaney, J.E., C.M. Upshaw, J.W. Hooton, K.E. Lechelt, and G.S. Meneilly. 1998. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 16: 1742–1747.PubMedCrossRef
110.
Zurück zum Zitat Wierenga, E.A., M. Snoek, C. de Groot, I. Chretien, J.D. Bos, H.M. Jansen, et al. 1990. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. The Journal of Immunology 144: 4651–4656.PubMed Wierenga, E.A., M. Snoek, C. de Groot, I. Chretien, J.D. Bos, H.M. Jansen, et al. 1990. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. The Journal of Immunology 144: 4651–4656.PubMed
111.
Zurück zum Zitat Krakauer, T., and C. Russo. 2001. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacology and Immunotoxicology 23: 35–41.PubMedCrossRef Krakauer, T., and C. Russo. 2001. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacology and Immunotoxicology 23: 35–41.PubMedCrossRef
112.
Zurück zum Zitat Miyamasu, M., Y. Misaki, M. Yamaguchi, K. Yamamoto, Y. Morita, K. Matsushima, et al. 2000. Regulation of human eotaxin generation by Th1-/Th2-derived cytokines. International of Archives of Allergy and Immunology 122(Suppl 1): 54–58.CrossRef Miyamasu, M., Y. Misaki, M. Yamaguchi, K. Yamamoto, Y. Morita, K. Matsushima, et al. 2000. Regulation of human eotaxin generation by Th1-/Th2-derived cytokines. International of Archives of Allergy and Immunology 122(Suppl 1): 54–58.CrossRef
113.
Zurück zum Zitat Lilly, C.M., P.G. Woodruff, C.A. Camargo, H. Nakamura, J.M. Drazen, E.S. Nadel, et al. 1999. Elevated plasma eotaxin levels in patients with acute asthma. Journal of Allergy and Clinical Immunology 104: 786–790.PubMedCrossRef Lilly, C.M., P.G. Woodruff, C.A. Camargo, H. Nakamura, J.M. Drazen, E.S. Nadel, et al. 1999. Elevated plasma eotaxin levels in patients with acute asthma. Journal of Allergy and Clinical Immunology 104: 786–790.PubMedCrossRef
114.
Zurück zum Zitat Chu, Y.T., W. Chiang, T.N. Wang, C.H. Hung, Y.J. Jong, and J.R. Wu. 2007. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma. Journal of Microbiology, Immunology and Infection 40: 162–167. Chu, Y.T., W. Chiang, T.N. Wang, C.H. Hung, Y.J. Jong, and J.R. Wu. 2007. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma. Journal of Microbiology, Immunology and Infection 40: 162–167.
115.
Zurück zum Zitat Leung, D.Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. Journal of Allergy and Clinical Immunology 96: 302–318. quiz 319.PubMedCrossRef Leung, D.Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. Journal of Allergy and Clinical Immunology 96: 302–318. quiz 319.PubMedCrossRef
116.
Zurück zum Zitat Wuthrich, B., and P. Schmid-Grendelmeier. 2003. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated (“extrinsic”) and the nonallergic (“intrinsic”) AEDS. Journal of Investigation Allergology and Clinical Immunology 13: 1–5. Wuthrich, B., and P. Schmid-Grendelmeier. 2003. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated (“extrinsic”) and the nonallergic (“intrinsic”) AEDS. Journal of Investigation Allergology and Clinical Immunology 13: 1–5.
117.
Zurück zum Zitat Hossny, E., M. Aboul-Magd, and S. Bakr. 2001. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 56: 996–1002.PubMedCrossRef Hossny, E., M. Aboul-Magd, and S. Bakr. 2001. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 56: 996–1002.PubMedCrossRef
118.
Zurück zum Zitat Greiff, L., H. Petersen, E. Mattsson, M. Andersson, J.S. Erjefalt, M. Linden, et al. 2001. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clinical & Experimental Allergy 31: 1321–1327.CrossRef Greiff, L., H. Petersen, E. Mattsson, M. Andersson, J.S. Erjefalt, M. Linden, et al. 2001. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clinical & Experimental Allergy 31: 1321–1327.CrossRef
119.
Zurück zum Zitat Lloyd, C.M., T. Delaney, T. Nguyen, J. Tian, A.C. Martinez, A.J. Coyle, et al. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. The Journal of Experimental Medicine 191: 265–274.PubMedPubMedCentralCrossRef Lloyd, C.M., T. Delaney, T. Nguyen, J. Tian, A.C. Martinez, A.J. Coyle, et al. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. The Journal of Experimental Medicine 191: 265–274.PubMedPubMedCentralCrossRef
120.
Zurück zum Zitat Kaburagi, Y., Y. Shimada, T. Nagaoka, M. Hasegawa, K. Takehara, and S. Sato. 2001. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Archives of Dermatological Research 293: 350–355.PubMedCrossRef Kaburagi, Y., Y. Shimada, T. Nagaoka, M. Hasegawa, K. Takehara, and S. Sato. 2001. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Archives of Dermatological Research 293: 350–355.PubMedCrossRef
121.
Zurück zum Zitat Kagami, S., T. Kakinuma, H. Saeki, Y. Tsunemi, H. Fujita, K. Nakamura, et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clinical & Experimental Immunology 134: 309–313.CrossRef Kagami, S., T. Kakinuma, H. Saeki, Y. Tsunemi, H. Fujita, K. Nakamura, et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clinical & Experimental Immunology 134: 309–313.CrossRef
122.
Zurück zum Zitat Yawalkar, N., M. Uguccioni, J. Scharer, J. Braunwalder, S. Karlen, B. Dewald, et al. 1999. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. Journal of Investigate Dermatology 113: 43–48.CrossRef Yawalkar, N., M. Uguccioni, J. Scharer, J. Braunwalder, S. Karlen, B. Dewald, et al. 1999. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. Journal of Investigate Dermatology 113: 43–48.CrossRef
123.
Zurück zum Zitat Yamada, H., K. Hirai, M. Miyamasu, M. Iikura, Y. Misaki, S. Shoji, et al. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochemical Biophysical Research Communications 231: 365–368.PubMedCrossRef Yamada, H., K. Hirai, M. Miyamasu, M. Iikura, Y. Misaki, S. Shoji, et al. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochemical Biophysical Research Communications 231: 365–368.PubMedCrossRef
124.
Zurück zum Zitat Hatano, Y., K. Katagiri, and S. Takayasu. 1999. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clinical & Experimental Immunology 117: 237–243.CrossRef Hatano, Y., K. Katagiri, and S. Takayasu. 1999. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clinical & Experimental Immunology 117: 237–243.CrossRef
125.
Zurück zum Zitat Cheng, J.F., N.L. Ott, E.A. Peterson, T.J. George, M.J. Hukee, G.J. Gleich, et al. 1997. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. Journal of Allergy and Clinical Immunology 99: 683–692.PubMedCrossRef Cheng, J.F., N.L. Ott, E.A. Peterson, T.J. George, M.J. Hukee, G.J. Gleich, et al. 1997. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. Journal of Allergy and Clinical Immunology 99: 683–692.PubMedCrossRef
126.
Zurück zum Zitat Jahnz-Rozyk, K., T. Targowski, E. Paluchowska, W. Owczarek, and A. Kucharczyk. 2005. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60: 685–688.PubMedCrossRef Jahnz-Rozyk, K., T. Targowski, E. Paluchowska, W. Owczarek, and A. Kucharczyk. 2005. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60: 685–688.PubMedCrossRef
127.
Zurück zum Zitat Gahr, N., R. Folster-Holst, M. Weichenthal, E. Christophers, J.M. Schroder, and J. Bartels. 2011. Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation. British Journal of Dermatology 164: 586–592.PubMed Gahr, N., R. Folster-Holst, M. Weichenthal, E. Christophers, J.M. Schroder, and J. Bartels. 2011. Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation. British Journal of Dermatology 164: 586–592.PubMed
128.
Zurück zum Zitat Yang, G.Y., X. Chen, Y.C. Sun, C.L. Ma, and G. Qian. 2013. Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis. International Journal of Biological Sciences 9: 759–765.PubMedPubMedCentralCrossRef Yang, G.Y., X. Chen, Y.C. Sun, C.L. Ma, and G. Qian. 2013. Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis. International Journal of Biological Sciences 9: 759–765.PubMedPubMedCentralCrossRef
Metadaten
Titel
An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis
verfasst von
Zahra Ahmadi
Gholamhossein Hassanshahi
Hossein Khorramdelazad
Nahid Zainodini
Leila Koochakzadeh
Publikationsdatum
09.02.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0303-9

Weitere Artikel der Ausgabe 3/2016

Inflammation 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.